INOmax is a Respiratory (inhalation) Gas in the Human Prescription Drug category. It is labeled and distributed by Ino Therapeutics Llc. The primary component is Nitric Oxide.
Product ID | 64693-002_6bb422a7-69d8-4ded-96b6-c8632c097ad8 |
NDC | 64693-002 |
Product Type | Human Prescription Drug |
Proprietary Name | INOmax |
Generic Name | Nitric Oxide |
Dosage Form | Gas |
Route of Administration | RESPIRATORY (INHALATION) |
Marketing Start Date | 1999-12-23 |
Marketing Category | NDA / NDA |
Application Number | NDA020845 |
Labeler Name | INO THERAPEUTICS LLC |
Substance Name | NITRIC OXIDE |
Active Ingredient Strength | 1 mg/L |
Pharm Classes | Vasodilation [PE],Vasodilator [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 1999-12-23 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA020845 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1999-12-23 |
Marketing Category | NDA |
Application Number | NDA020845 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1999-12-23 |
Ingredient | Strength |
---|---|
NITRIC OXIDE | .98 mg/L |
SPL SET ID: | 762b51be-1893-4cd1-9511-e645fc420d3a |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
64693-002 | INOmax | nitric oxide |
72385-001 | GENOSYL | nitric oxide |
72385-002 | GENOSYL | nitric oxide |
80519-301 | NOW st | NITRIC OXIDE |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
INOMAX 79026770 3280185 Live/Registered |
Therakos, Inc. 2006-04-04 |
INOMAX 75342495 2185947 Live/Registered |
MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED 1997-08-18 |
INOMAX 74614450 not registered Dead/Abandoned |
OHMEDA PHARMACEUTICAL PRODUCTS DIVISIONINC. 1994-12-22 |